France: Biocodex targets US market with Hilma acquisition

Biocodex, a pharmaceutical company specialising in microbiota and women’s health, has acquired a majority stake in Hilma, a start-up specializing in natural remedies in the US, as part of its international growth strategy. It will enable Biocodex to consolidate its presence in the digestive health and women’s health segments of the US market. Hilma makes…

You must be a HMI Subscriber to view this content.

Subscribe Now »